![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 31, 2023 2:51:22 AM
It's inconceivable to you that a delayed filing represents anything beyond either managerial "incompetence or fraud." There's no way you comprehend the strategic advantage management has gained by positioning the company where it is. Granted, with the historically negative context associated with a company being "kicked down" to the Expert Market, it isn't easy to see anything good about that, even if the move was intentional. Sorry, but sometimes truth can be difficult to understand, until the reasoning is revealed, as it will be soon. Hell, I hope it's today.
Nothing has caused me to question the truth of the reported safety and efficacy data of lenz, detailed in PR's referencing data that has been peer-reviewed by both Lancet and Thorax. Yet, you cast doubt, and possibly detract new investors, by your wondering " if anything that was claimed was true." And don't give me what the class action lawyers said again. I've made it abundantly clear that they based their case on data obtained in treating late-stage patients in the government-sponsored trial, just the opposite of the company's trial of early-stage patients.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM